Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Nurix Therapeutics, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
Prev close 24.83 · gapped above the open, then crossed back over prior close. High/low 25.08 at 9:30 am ET, 24.30 at 1:15 pm ET.
212 institutional managers report a position in Nurix Therapeutics, Inc. worth $2.9B between them, filed on form 13F for the quarter ending 2026-06-30. 27 of them hold 80% of it, the largest being BlackRock, Inc. at 7.46%.
187 more managers in the register
27 managers hold 80% of the $2.9B institutional base. The other 185 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
via Vestal Point Capital, LP, Baker Bros. Advisors LP, Perceptive Advisors LLC +3 more · 6.85% of NRIX, 6.19% of IMTX
via Vestal Point Capital, LP, Deep Track Capital, LP, Woodline Partners LP +1 more · 6.85% of NRIX, 7.50% of BCAX
via Deep Track Capital, LP, Baker Bros. Advisors LP, Perceptive Advisors LLC +3 more · 6.58% of NRIX, 8.31% of IMVT
via Rubric Capital Management LP, Baker Bros. Advisors LP, Pictet Asset Management Holding SA +5 more · 6.15% of NRIX, 8.45% of KNSA
via Deep Track Capital, LP, Perceptive Advisors LLC, Trails Edge Capital Partners, LP +2 more · 6.58% of NRIX, 5.90% of XFOR
via Deep Track Capital, LP, Baker Bros. Advisors LP, Eventide Asset Management, LLC +12 more · 6.58% of NRIX, 3.43% of CLDX
Managers holding a meaningful stake in NRIX also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.
NRIX (Nurix Therapeutics, Inc.) has 2 disclosed suppliers and 6 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: PIPR +0.15%, in financials.